Following an amended proposal from medical imaging software vendor Merge Healthcare to acquire rival AMICAS Inc., Boston-based AMICAS has concluded that the proposal now is superior to an earlier acquisition offer from investment firm Thoma Bravo, LLC.
Milwaukee-based Merge recently made an unsolicited bid of $6.05 per share, compared with Thoma Bravo's $5.35 bid. AMICAS initially rejected Merge's offer, questioning how solid the financing arrangements were.
Now satisfied with those arrangements, AMICAS will offer to negotiate in good faith with Thoma Bravo during the five business day period ending March 8. Afterward, AMICAS will terminate its agreement with Thoma Bravo if the Merge proposal continues to be superior.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access